Epidyolex 100 mg / 1 ml, Lösung zum Einnehmen

7680675900015 CH-67590 Lösung

Associated product:

EPIDYOLEX sol 100 mg/ml fl 100 ml
Epidyolex 100 mg / 1 ml, Lösung zum Einnehmen
Epidyolex 100 mg / 1 ml, Lösung zum Einnehmen
Epidyolex 100 mg / 1 ml, Lösung zum Einnehmen
1 / 3
google

Article details

Package size
100
Selling units
100
Measure
ml
Galenic form
Lösung
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
05/04/2025
Patient information leaflet
Français
05/04/2025
Patient information leaflet
Italien
05/04/2025
Summary of Product Characteristics
Allemand
11/12/2023
Summary of Product Characteristics
Français
11/12/2023
Summary of Product Characteristics
Italien
11/12/2023

Detailed composition

Substance Quantity Type Category
(N/A)
100.0 MG Substance Wirkstoff (Principe actif)
(N/A)
79.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.3 UG Substance HBESI
(N/A)
736.0 MG Substance HBESI

Reimbursement information

Public price
CHF 1078.60
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/01/2025

Authorization holder

Jazz Pharmaceuticals

6300 Zug

Authorization information

Swissmedic authorization number
67590
Drug name
Epidyolex, Lösung zum Einnehmen
Galenic form
LSOR
ATC Code
N03AX24
Authorization status
Z
Dispensing category
A
First authorization
10/02/2021
Authorization expiration date
31/12/9999
IT Number
01.07.1.
Domain
Human medicine
Field of application
Zusatztherapie bei Krampfanfällen bei Patienten ab 2 Jahren mit Lennox-Gastaut-Syndrom (LGS), Dravet-Syndrom (DS) oder der Tuberösen Sklerose (TSC)

Package details

Description (FR)
EPIDYOLEX sol 100 mg/ml fl 100 ml
Description (DE)
EPIDYOLEX Lös 100 mg/ml Fl 100 ml
Market launch
10/02/2021
Narcotic (BTM)
No